Moreover, the activation of VEGF/VEGFR and FGF/FGFR pathways in GIST T-1R cells (associated with significant decrease in KIT expression and the absence of secondary KIT mutations) renders them highly sensitive to the inhibition of the aforementioned signaling cascades by the corresponding RTKi. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.